Health Tip of the Week, sponsored by Baton Rouge General: What we know about Zepbound, the new weight loss drug

The FDA recently approved a new drug called Zepbound that’s expected to hit the shelves before Christmas and promises to be one of the most effective weight management medications on the market. It belongs to the same class of medications as Mounjaro and Ozempic. For Zepbound, manufacturers used tirzepatide, the same active ingredient found in Mounjaro, to mimic a hormone that helps reduce food cravings. Zepbound has been approved for use in those at least 18 years old with a body mass index (BMI) of at least 30, or with a BMI of 27 or higher plus a weight-related condition like heart disease, high blood pressure or sleep apnea, to name a few. Learn more about the new weight loss drug.